Clinical trial

The Boston Scientific ACCESS Trial

NCT00260728 · Maquet Cardiovascular, Industry · Terminated

Key facts

NCT number NCT00260728
Title The Boston Scientific ACCESS Trial
Official title ACCESS: Prospective, Multi-center Trial of the Fusion Vascular Access Graft for Patients Who Require Early Vascular Access for Hemodialysis
Acronym ACCESS
Lead sponsor Maquet Cardiovascular, Industry
Status Terminated
Phase Phase 2/Phase 3
Study type Interventional
Conditions Renal Disease, Kidney Failure
Intervention type Device
Interventions vascular access graft implantation
Enrollment 149
Start date Dec 1, 2005
Primary completion May 1, 2007
Completion Dec 1, 2008
First posted Dec 2, 2005
Last update posted Jun 27, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies